A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Female Subjects.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Female Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 May 2012

At a glance

  • Drugs Betahistine (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors OBEcure
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 May 2009 Planned number of patients changed from 180 to 187 as reported by ClinicalTrials.gov.
    • 20 Jan 2009 Status changed from recruiting to active, no longer recruiting, according to an Obecure media release. Results are expected by the end of Q2 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top